[Toxophilic effects of morphinomimetic substances. Dopamine/enkephalin interactions in the ventral tegmental area and in the nucleus accumbens].
Stinus
L
L
INSERM U 259, Psychobiologie des Comportements adaptatifs, Universitéde Bordeaux II.
Cesselin
F
F
Deminière
J M
JM
Bourgouin
S
S
Hamon
M
M
Le Moal
M
M
D000818:Animals; D004298:Dopamine / Q000502:physiology*; D004745:Enkephalins / Q000494:pharmacology*; D005475:Flupenthixol / Q000031:analogs & derivatives / Q000494:pharmacology; D006556:Heroin Dependence / Q000503:physiopathology; D009020:Morphine / Q000494:pharmacology*; D009270:Naloxone / Q000494:pharmacology; D009714:Nucleus Accumbens / Q000187:drug effects*; D051381:Rats; D011957:Receptors, Opioid / Q000502:physiology*; D012686:Septal Nuclei / Q000187:drug effects*; D013681:Tegmentum Mesencephali / Q000187:drug effects*
D004745:Enkephalins; D011957:Receptors, Opioid; D009270:Naloxone; C007761:flupenthixol decanoate; D009020:Morphine; D005475:Flupenthixol; D004298:Dopamine
Effets toxicophiliques des morphinomimétiques. Interactions dopamine-enképhaline dans l'aire tegmentale ventrale et dans le noyau accumbens.